Eisai's Eribulin (Halaven(R)) Receives Swissmedic Approval For Use In Locally Advance

		HER2 Support Group Forums > Breast Cancer Newsfeed
Eisai's Eribulin (Halaven(R)) Receives Swissmedic Approval For Use In Locally Advance

05-18-2011, 03:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,138	Eisai's Eribulin (Halaven(R)) Receives Swissmedic Approval For Use In Locally Advance Eribulin (Halaven(R)) is today approved for use in Switzerland by Swissmedic, the Swiss Agency for Therapeutic Products, as a monotherapy treatment of patients with locally advanced and metastatic breast carcinoma with progression after prior therapy with an anthracycline, a taxane and capecitabine... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:59 PM.